- Home
- U vs ARWR Comparison
U vs ARWR Comparison
Compare U & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | U | ARWR |
|---|---|---|
| Founded | 2004 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0B | 9.3B |
| IPO Year | 2020 | 2009 |
Fundamental Metrics
Financial Performance| Metric | U | ARWR |
|---|---|---|
| Price | $23.35 | $66.61 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 21 | 10 |
| Target Price | $36.61 | ★ $81.50 |
| AVG Volume (30 Days) | ★ 14.5M | 1.7M |
| Earning Date | 05-07-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 42.86 | ★ 99.80 |
| EPS | N/A | ★ 0.22 |
| Revenue | ★ $1,849,648,000.00 | $16,142,321.00 |
| Revenue This Year | $15.70 | N/A |
| Revenue Next Year | $12.90 | N/A |
| P/E Ratio | ★ N/A | $290.73 |
| Revenue Growth | ★ 2.01 | N/A |
| 52 Week Low | $16.78 | $10.92 |
| 52 Week High | $52.15 | $76.76 |
Technical Indicators
Market Signals| Indicator | U | ARWR |
|---|---|---|
| Relative Strength Index (RSI) | 60.36 | 62.01 |
| Support Level | $16.91 | $60.60 |
| Resistance Level | $39.33 | $71.83 |
| Average True Range (ATR) | 1.34 | 3.22 |
| MACD | 0.52 | 0.86 |
| Stochastic Oscillator | 90.86 | 92.72 |
Price Performance
Historical ComparisonAbout U Unity Software Inc.
Unity Software Inc provides a software platform for creating and operating interactive, real-time 3D content. The platform can be used to create, run, and monetize interactive, real-time 2D and 3D content for mobile phones, tablets, PCs, consoles, and augmented and virtual reality devices. The business is spread across the United States, Greater China, EMEA, APAC, and other Americas, and key revenue is derived from the EMEA region. Its products are used in the gaming industry, retail, automotive, architecture, engineering, and construction.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.